Pinja Jalkanen

610 total citations
12 papers, 83 citations indexed

About

Pinja Jalkanen is a scholar working on Infectious Diseases, Surgery and Neurology. According to data from OpenAlex, Pinja Jalkanen has authored 12 papers receiving a total of 83 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 2 papers in Surgery and 2 papers in Neurology. Recurrent topics in Pinja Jalkanen's work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Pinja Jalkanen is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). Pinja Jalkanen collaborates with scholars based in Finland and Italy. Pinja Jalkanen's co-authors include Ilkka Julkunen, Anu Kantele, Paula A. Tähtinen, Johanna Lempainen, Lauri Ivaska, Merit Melin, Laura Kakkola, Jarmo Oksi, Seppo Meri and Johanna Teräsjärvi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Pinja Jalkanen

10 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pinja Jalkanen Finland 6 58 24 13 12 11 12 83
Shane Cloney-Clark Australia 7 80 1.4× 33 1.4× 20 1.5× 7 0.6× 10 0.9× 12 111
Daniel Louiselle United States 7 101 1.7× 25 1.0× 53 4.1× 6 0.5× 20 1.8× 10 171
Sebastian Einhauser Germany 8 121 2.1× 21 0.9× 31 2.4× 11 0.9× 15 1.4× 14 146
Nathalie Vittoz France 3 85 1.5× 8 0.3× 13 1.0× 9 0.8× 25 2.3× 4 117
Rebecca Biswell United States 2 96 1.7× 29 1.2× 39 3.0× 5 0.4× 20 1.8× 2 152
Richard Baguma South Africa 5 78 1.3× 32 1.3× 23 1.8× 5 0.4× 4 0.4× 5 85
Samuel Wrenn United States 3 165 2.8× 12 0.5× 27 2.1× 23 1.9× 7 0.6× 3 180
Benjamin Chung United States 2 105 1.8× 15 0.6× 16 1.2× 23 1.9× 5 0.5× 2 123
Victoria Giffin United States 2 103 1.8× 14 0.6× 16 1.2× 23 1.9× 5 0.5× 3 122
Eric Wang United States 5 52 0.9× 25 1.0× 20 1.5× 15 1.3× 4 0.4× 9 84

Countries citing papers authored by Pinja Jalkanen

Since Specialization
Citations

This map shows the geographic impact of Pinja Jalkanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pinja Jalkanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pinja Jalkanen more than expected).

Fields of papers citing papers by Pinja Jalkanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pinja Jalkanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pinja Jalkanen. The network helps show where Pinja Jalkanen may publish in the future.

Co-authorship network of co-authors of Pinja Jalkanen

This figure shows the co-authorship network connecting the top 25 collaborators of Pinja Jalkanen. A scholar is included among the top collaborators of Pinja Jalkanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pinja Jalkanen. Pinja Jalkanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Nissilä, Eija, Pinja Jalkanen, Katarzyna Leskinen, et al.. (2025). The COVID‐19 vaccine ChAdOx1 is opsonized by anti‐vector antibodies that activate complement and promote viral vector phagocytosis. Scandinavian Journal of Immunology. 101(2). e70000–e70000.
2.
3.
Teräsjärvi, Johanna, Pinja Jalkanen, Thijs Feuth, et al.. (2025). Post-COVID-19 condition in prospective inpatient and outpatient cohorts. Scientific Reports. 15(1). 6925–6925. 1 indexed citations
4.
Reinholm, Arttu, Pekka Kolehmainen, Sari Maljanen, et al.. (2024). Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity. Frontiers in Immunology. 15. 1494432–1494432. 1 indexed citations
5.
Jalkanen, Pinja, et al.. (2023). T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency – a 22-month follow-up. Frontiers in Immunology. 14. 1146500–1146500. 5 indexed citations
6.
Ekström, Nina, Camilla Virta, Pamela Österlund, et al.. (2022). Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection. Open Forum Infectious Diseases. 9(12). ofac625–ofac625. 4 indexed citations
7.
Jalkanen, Pinja, Merit Melin, Johanna Teräsjärvi, et al.. (2022). Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients. Frontiers in Immunology. 13. 869990–869990. 33 indexed citations
8.
Jalkanen, Pinja, Pekka Kolehmainen, Moona Huttunen, et al.. (2022). Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination. Microbiology Spectrum. 10(2). e0225221–e0225221. 10 indexed citations
9.
Kopra, Kari, Nazia Hassan, Pinja Jalkanen, et al.. (2022). Rapid high-throughput compatible label-free virus particle quantification method based on time-resolved luminescence. Analytical and Bioanalytical Chemistry. 414(15). 4509–4518. 3 indexed citations
10.
Kolehmainen, Pekka, Pinja Jalkanen, Moona Huttunen, et al.. (2022). Serological Follow-Up Study Indicates High Seasonal Coronavirus Infection and Reinfection Rates in Early Childhood. Microbiology Spectrum. 10(3). e0196721–e0196721. 7 indexed citations
11.
Jouppila, Annukka, Seppo Meri, Anu Kantele, et al.. (2021). COVID-19 adenovirus vaccine triggers antibodies against PF4 complexes to activate complement and platelets. Thrombosis Research. 208. 129–137. 14 indexed citations
12.
Melén, Krister, Pinja Jalkanen, Jyrki P. Kukkonen, et al.. (2020). No evidence of autoimmunity to human OX1 or OX2 orexin receptors in Pandemrix-vaccinated narcoleptic children. SHILAP Revista de lepidopterología. 3. 100055–100055. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shane Cloney-Clark Breakdown of academic impact, for papers by Daniel Louiselle Breakdown of academic impact, for papers by Sebastian Einhauser Breakdown of academic impact, for papers by Nathalie Vittoz Breakdown of academic impact, for papers by Rebecca Biswell Breakdown of academic impact, for papers by Richard Baguma Breakdown of academic impact, for papers by Samuel Wrenn Breakdown of academic impact, for papers by Benjamin Chung Breakdown of academic impact, for papers by Victoria Giffin Breakdown of academic impact, for papers by Eric Wang
Rankless by CCL
2026